1. Division of Endocrinology and Diabetology, Philipp’s University Hospital, Marburg, Germany,
2. Department of Neuroendocrinology, Max-Planck-Institute for Psychiatry, Munich, Germany,
3. Department of Endocrinology and Metabolism, Johannes Gutenberg University Hospital, Mainz, Germany,
4. Epidemiology, Novo Nordisk A/S, Søborg, Denmark, and
5. Novo Nordisk Pharma GmbH, Mainz, Germany